Bank of Montreal’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,183
| Closed | -$244K | – | 3666 |
|
|
2024
Q4 | $244K | Buy |
+8,183
| New | +$173K | ﹤0.01% | 2661 |
|
|
2023
Q4 | – | Sell |
-21,314
| Closed | -$412K | – | 4216 |
|
|
2023
Q3 | $412K | Buy |
21,314
+4,901
| +30% | +$141K | ﹤0.01% | 2577 |
|
|
2023
Q2 | $1.22M | Buy |
16,413
+3,246
| +25% | +$202K | ﹤0.01% | 2069 |
|
|
2023
Q1 | $793K | Buy |
13,167
+13
| +0.1% | +$1.04K | ﹤0.01% | 2193 |
|
|
2022
Q4 | $980K | Sell |
13,154
-7,481
| -36% | -$563K | ﹤0.01% | 2187 |
|
|
2022
Q3 | $1.81K | Buy |
20,635
+337
| +2% | +$26.3K | ﹤0.01% | 1869 |
|
|
2022
Q2 | $1.48K | Sell |
20,298
-219
| -1% | -$16.5K | ﹤0.01% | 2063 |
|
|
2022
Q1 | $1.75M | Buy |
20,517
+957
| +5% | +$70.5K | ﹤0.01% | 2012 |
|
|
2021
Q4 | $1.57M | Sell |
19,560
-101,041
| -84% | -$10.1M | ﹤0.01% | 1706 |
|
|
2021
Q3 | $15.4M | Buy |
120,601
+101,537
| +533% | +$15.4M | 0.01% | 1062 |
|
|
2021
Q2 | $4.27M | Buy |
19,064
+3,087
| +19% | +$601K | ﹤0.01% | 1679 |
|
|
2021
Q1 | $2.12M | Sell |
15,977
-142
| -0.9% | -$22.5K | ﹤0.01% | 1771 |
|
|
2020
Q4 | $2.74M | Buy |
16,119
+628
| +4% | +$85.9K | ﹤0.01% | 1685 |
|
|
2020
Q3 | $1.85M | Sell |
15,491
-31,866
| -67% | -$2.55M | ﹤0.01% | 1693 |
|
|
2020
Q2 | $2.84M | Buy |
47,357
+328
| +0.7% | +$21.6K | ﹤0.01% | 1456 |
|
|
2020
Q1 | $3.12M | Sell |
47,029
-31,009
| -40% | -$2.45M | ﹤0.01% | 1201 |
|
|
2019
Q4 | $6.58M | Buy |
78,038
+38,604
| +98% | +$3.12M | ﹤0.01% | 1207 |
|
|
2019
Q3 | $2.95M | Sell |
39,434
-6,963
| -15% | -$557K | ﹤0.01% | 1443 |
|
|
2019
Q2 | $2.93M | Buy |
46,397
+32,148
| +226% | +$1.63M | ﹤0.01% | 1460 |
|
|
2019
Q1 | $686K | Sell |
14,249
-2,146
| -13% | -$103K | ﹤0.01% | 2173 |
|
|
2018
Q4 | $550K | Sell |
16,395
-1,999
| -11% | -$73.1K | ﹤0.01% | 2131 |
|
|
2018
Q3 | $963K | Buy |
18,394
+9,015
| +96% | +$359K | ﹤0.01% | 2021 |
|
|
2018
Q2 | $293K | Buy |
9,379
+2,310
| +33% | +$64.3K | ﹤0.01% | 2592 |
|
|
2018
Q1 | $154K | Hold |
7,069
| – | – | ﹤0.01% | 2750 |
|
|
2017
Q4 | $143K | Hold |
7,069
| – | – | ﹤0.01% | 2838 |
|
|
2017
Q3 | $140K | Hold |
7,069
| – | – | ﹤0.01% | 2829 |
|
|
2017
Q2 | $122K | Buy |
7,069
+6,719
| +1,920% | +$86.7K | ﹤0.01% | 2900 |
|
|
2017
Q1 | $3K | Hold |
350
| – | – | ﹤0.01% | 3779 |
|
|
2016
Q4 | $3K | Hold |
350
| – | – | ﹤0.01% | 3834 |
|
|
2016
Q3 | $3K | Hold |
350
| – | – | ﹤0.01% | 3801 |
|
|
2016
Q2 | $4K | Hold |
350
| – | – | ﹤0.01% | 3795 |
|
|
2016
Q1 | $5K | Buy |
+350
| New | +$5.02K | ﹤0.01% | 3789 |
|
Other funds holding NVCR
SCM
Bank of Montreal's NVCR Position: Q1 2025 in Review
Bank of Montreal sold out of NovoCure (NVCR) in Q1 2025, closing a stake of 8,183 shares — an estimated $244K sold.
Bank of Montreal first reported a position in NVCR in Q1 2016 and held it in 32 quarters. The position peaked at $15.4M in Q3 2021. 228 funds tracked by Wall St. Rank hold NVCR as of Q1 2025.
- Bank of Montreal reported no remaining NovoCure position as of Q1 2025 after selling out during the quarter.
- Bank of Montreal sold 8,183 NovoCure shares in Q1 2025, an estimated $244K.
- Bank of Montreal first reported a position in NovoCure in Q1 2016 and held it in 32 quarters.
- Bank of Montreal's NovoCure position peaked at $15.4M in Q3 2021.
- 228 funds tracked by Wall St. Rank held NovoCure as of Q1 2025.
Based on Bank of Montreal's 13F filing for Q1 2025, filed 13 May 2025.